If a treatment is shown to increase human lifespan in a randomized controlled trial by 2030, what was the treatment?

255Ṁ276

2030

ALL

1.8%

Metformin

22%

Calorie restriction

10%

Rapamycin

67%

Other

Resolves according to the intervention in the study that causes this market to resolve YES, if it resolves YES, and N/A otherwise.

Longevity

Get

1,000

to start trading!

People are also trading

By 2030, will any treatment be shown to increase human lifespan in a randomized controlled trial?

Will a therapy that substantially slows down or reverses the aging process in humans be developed before 2040?

65% chance

Will any company successfully develop a therapeutic treatment that rejuvenates healthspan by at least 10 years by 2030?

39% chance

ITP: Which drug(s) will increase median lifespan the most in males by 2030?

What will be the next compound produced and tested by the ITP that will be shown to have a statistically significant effect on both median and 90th percentile lifespan?

When will at least 5% of the world population be undergoing treatments expected to extend their lives at least 10 years?

Will NR or NMN supplementation by proven to promote longevity-related outcomes in healthy adults by 2025?

15% chance

What country will be the first to have a proven treatment that will have a significant increase maximum life expectancy?

By 2030, will there be a cure to aging?

11% chance

Will a study show that the combination of parabiosis + genetic reprogramming will improve lifespan more than either intervention alone by 2035?

Sort by:

How exactly will 'calorie restriction' resolve- I think 'eating less calories' would measurably increase lifespan if the whole US population did it, because a lot of it is obese?

10k no limit on rapamycin 1 day only

How much an improvement do you need? E.g. would statins qualify if they weren't already known?

@MartinModrak Alyssa Vance says on the other market that this one is conditioned on:
> Any effect size counts, as long as the trial clearly shows that it actually exists. (In practice, very small effect sizes would be impossible to show in this way, because the sample size goes as the inverse square of the effect size. So a treatment which extended life one week would be impossible to prove, because you'd need zillions of people.)

If statins already have such a trial, that would be interesting; seems that it would count as a YES resolution for that market and a Statins resolution for this market, though I'm following Alyssa's resolution there.